Characterization of vernix caseosa as a natural biofilm: comparison to standard oil-based ointments.
The application of occlusive films and oil-in-oil ointments has been reported to improve epidermal barrier function in very low birthweight, preterm infants. Such infants have a structurally immature stratum corneum and lack a surface coating of vernix caseosa. In this study we examined the short-term effects of topical application of vernix caseosa to human skin and contrasted these effects with commonly used ointments and water-in-oil emulsions. Specifically, vernix, Eucerin(R), Aquaphor(R), and petrolatum were applied to the volar skin surface of adult volunteers. Surface electrical capacitance (SEC) and transepidermal water loss (TEWL) were measured as indices of surface hydration. Sorption-desorption profiles were performed to determine skin surface hydrophobicity. Particular attention was given to monitoring the acute (0-120 minutes) changes following vernix treatment in order to compare these effects with earlier reports on the rate of skin surface drying in newborn infants following birth. Immediately after vernix application there was an increase in the rate of water loss from the skin surface. Relative to control skin and skin treated with the ointments and water-in-oil emulsions, the application of vernix to freshly bathed human skin resulted in a unique profile of temporal change in baseline surface hydration, moisture accumulation, and water-holding capacity. These results demonstrate major differences between human vernix and standard oil-based topical ointments. The results provide a framework for discussing the various properties of topical barriers applied to the very low birthweight infant.
Bautista
M I
MI
Skin Sciences Institute, Children's Hospital Research Foundation, University of Cincinnati, Cincinnati, Ohio 45267-0541, USA.
Wickett
R R
RR
Visscher
M O
MO
Pickens
W L
WL
Hoath
S B
SB
D000328:Adult; D019540:Area Under Curve; D004643:Emollients / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D007231:Infant, Newborn; D008875:Middle Aged; D009823:Ointment Bases; D009824:Ointments / Q000493:pharmacokinetics / Q000494:pharmacology; D012867:Skin / Q000187:drug effects / Q000378:metabolism; D012869:Skin Absorption / Q000187:drug effects; D012879:Skin Physiological Phenomena / Q000187:drug effects; D014708:Vernix Caseosa; D014870:Water Loss, Insensible / Q000187:drug effects
D004643:Emollients; D009823:Ointment Bases; D009824:Ointments